Smith & Nephew SNATS - 21 Year Stock Price History | SNN

Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits. The latest closing stock price for Smith & Nephew SNATS as of August 04, 2020 is 40.17.
  • The all-time high Smith & Nephew SNATS stock closing price was 51.64 on February 20, 2020.
  • The Smith & Nephew SNATS 52-week high stock price is 52.26, which is 30.1% above the current share price.
  • The Smith & Nephew SNATS 52-week low stock price is 26.07, which is 35.1% below the current share price.
  • The average Smith & Nephew SNATS stock price for the last 52 weeks is 43.41.
Smith & Nephew SNATS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 41.7090 48.2700 51.6400 27.7800 40.1700 -16.43%
2019 42.7863 36.4000 48.5900 35.5100 48.0700 28.60%
2018 36.3446 34.9000 39.4400 32.4000 37.3800 6.77%
2017 34.1090 29.9900 38.5000 29.9000 35.0100 16.39%
2016 32.3880 34.8000 35.0600 27.1100 30.0800 -15.51%
2015 35.0108 35.9500 37.7800 32.4800 35.6000 -3.10%
2014 32.9098 28.3360 38.9080 28.3360 36.7400 28.03%
2013 24.0164 22.2920 28.7400 21.1600 28.6960 29.49%
2012 20.3023 19.5560 22.4640 18.0520 22.1600 15.06%
2011 20.5597 21.0400 24.0760 16.8680 19.2600 -8.37%
2010 19.1278 20.6520 21.5760 16.5160 21.0200 2.54%
2009 15.8762 13.0400 20.5520 12.2280 20.5000 58.67%
2008 21.6752 23.0520 27.4280 12.1560 12.9200 -43.75%
2007 24.1161 20.9480 27.1080 20.8280 22.9680 9.73%
2006 17.8203 18.9440 21.0600 14.7800 20.9320 12.90%
2005 19.1965 20.3320 21.1320 16.1040 18.5400 -10.45%
2004 19.6518 16.7360 23.2000 16.3200 20.7040 23.47%
2003 13.2164 12.3720 16.9200 10.7200 16.7680 36.55%
2002 11.5938 12.0600 12.7820 9.6800 12.2800 0.99%
2001 9.9700 9.2000 12.1800 8.3700 12.1600 31.83%
2000 7.9306 8.2180 9.2240 6.1403 9.2240 12.01%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.809B $5.138B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.087B 33.45
Medtronic (MDT) Ireland $130.549B 21.20
Stryker (SYK) United States $71.817B 27.85
Boston Scientific (BSX) United States $53.175B 31.41
Lonza Group Ag (LZAGY) Switzerland $47.258B 0.00
Baxter (BAX) United States $42.098B 25.75
Terumo (TRUMY) Japan $29.607B 37.85
ResMed (RMD) United States $29.223B 46.12
EssilorLuxottica Societe Anonyme (ESLOY) France $28.452B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.63
Sunny Optical Technology (SNPTF) China $20.336B 0.00
Bio-Rad Laboratories (BIO) United States $15.744B 71.28
Insulet (PODD) United States $12.772B 1265.31
Quidel (QDEL) United States $12.326B 65.29
Shandong Weigao Medical Polymer (SHWGF) China $12.301B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
Perrigo (PRGO) Ireland $7.465B 13.36
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.069B 0.00
Hill-Rom Holdings (HRC) United States $6.374B 15.82
Haemonetics (HAE) United States $4.386B 26.34
GW Pharmaceuticals (GWPH) United Kingdom $4.125B 0.00
Neogen (NEOG) United States $4.103B 68.55
ICU Medical (ICUI) United States $3.829B 27.93
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.787B 0.00
Envista Holdings (NVST) United States $3.527B 24.05
Abcam (ABCZY) $3.484B 0.00
Agios Pharmaceuticals (AGIO) United States $3.245B 0.00
NuVasive (NUVA) United States $2.857B 22.94
National Vision Holdings (EYE) United States $2.647B 45.79
TG Therapeutics (TGTX) United States $2.293B 0.00
AtriCure (ATRC) United States $1.871B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.649B 151.85
MacroGenics (MGNX) United States $1.445B 0.00
Aphria (APHA) Canada $1.413B 0.00
NanoString Technologies (NSTG) United States $1.402B 0.00
Cerus (CERS) United States $1.215B 0.00
Aurora Cannabis (ACB) Canada $1.203B 0.00
OraSure Technologies (OSUR) United States $1.189B 239.38
Vapotherm (VAPO) United States $1.128B 0.00
Meridian Bioscience (VIVO) United States $1.113B 41.92
Cardiovascular Systems (CSII) United States $1.102B 0.00
Owens & Minor (OMI) United States $1.072B 28.35
InMode (INMD) Israel $1.071B 22.64
PetIQ (PETQ) United States $1.055B 30.47
Phibro Animal Health (PAHC) United States $0.946B 18.86
Quanterix (QTRX) United States $0.914B 0.00
Omeros (OMER) United States $0.698B 0.00
BioLife Solutions (BLFS) United States $0.671B 191.00
Zynex (ZYXI) United States $0.656B 57.24
Eagle Pharmaceuticals (EGRX) United States $0.653B 46.78
Surmodics (SRDX) United States $0.651B 78.39
VAREX IMAGING (VREX) United States $0.625B 15.52
LeMaitre Vascular (LMAT) United States $0.609B 37.26
Lantheus Holdings (LNTH) United States $0.529B 12.31
Viemed Healthcare (VMD) United States $0.429B 38.07
Cytosorbents (CTSO) United States $0.346B 0.00
HEXO (HEXO) $0.336B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.26
InfuSystems Holdings (INFU) United States $0.249B 137.67
Organigram Holdings (OGI) Canada $0.225B 0.00
Female Health (VERU) United States $0.199B 0.00
Chimerix (CMRX) United States $0.194B 0.00
Fonar (FONR) United States $0.160B 14.20
Bovie Medical (APYX) United States $0.159B 0.00
Exagen (XGN) United States $0.157B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Wound Management Technologies (SMTI) United States $0.135B 0.00
Liberty Health Sciences (LHSIF) Canada $0.130B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.110B 0.00
Evolus (EOLS) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.089B 0.00
Nephros (NEPH) United States $0.074B 0.00
United-Guardian (UG) United States $0.068B 15.87
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
FSD PHARMA INC (HUGE) Canada $0.029B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00